loader
Please Wait
Applying Filters...
menu
    • menu

    Others: Fermion's long term customer G1 Therapeutics received FDA approval for COSELA™ (Trilaciclib) - Fermion Oy

    MenuFermion Oy

    Uploaded: 2022
    News
    Fermion Expands API Capacity with Hanko Site Renovation

    07 Aug 2025

    // PRESS RELEASE

    Crystallization as a Core Competence in API Manufacturing

    17 Jun 2025

    // PRESS RELEASE

    New Micronization Equipment at Fermion Oulu plant

    23 Apr 2025

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    Fermion VB

    Contact Supplier

    Website

    DCAT Week

    Attending

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.pharmacompass.com/video-pharmareel/fermion-oy/partner-in-generic-apis-cdmo-services
    Xls

    CATEGORY PAGE
    Menu

    Fermion Oy

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    Key Products KEY PRODUCTS

    SERVICES

    Key Services KEY SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    PC100349
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.